Zhiquan Hu
Clinical trials sponsored by Zhiquan Hu, explained in plain language.
-
Can a targeted drug combo boost tumor clearance in rare kidney tract cancer?
Disease control Recruiting nowThis trial is investigating whether giving a combination of gemcitabine and trastuzumab rezetecan before surgery can improve outcomes for people with HER2-positive upper tract urothelial carcinoma, a rare cancer of the kidney's drainage system. Participants will receive four cycl…
Phase 2 • Sponsor: Zhiquan Hu • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC
-
New drug cocktail aims to wipe out bladder cancer before surgery
Disease control Recruiting nowThis phase 3 trial tests whether combining the targeted drug disitamab vedotin (RC48) with chemotherapy (gemcitabine) before surgery works as well as RC48 plus an immunotherapy (toripalimab) for people with HER2-positive muscle-invasive bladder cancer. Participants receive one of…
Phase 3 • Sponsor: Zhiquan Hu • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC